Evidence map›Paper›PMID 33692694›Full record

ArticleFrontiers in pharmacology2021

Ginger Alleviates DSS-Induced Ulcerative Colitis Severity by Improving the Diversity and Function of Gut Microbiota.

Shanshan Guo, Wenye Geng, Shan Chen, Li Wang, Xuli Rong, Shuocun Wang, Tingfang Wang, Liyan Xiong, Jinghua Huang, Xiaobin Pang and 1 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Exploration of theNutrients · 2024
    Review
  11. Article
  12. Effects of Ginger (Biomolecules · 2024
    Review
  13. Molecules (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Review
  16. Cells · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shanshan GuoSchool of Medicine, Shanghai University, Shanghai, China.
Wenye GengInstitutes of Integrative Medicine, Fudan University, Shanghai, China.
Shan ChenEight Plus One Pharmaceutical Co., Ltd, Guilin, China.
Li WangEight Plus One Pharmaceutical Co., Ltd, Guilin, China.
Xuli RongSchool of Pharmacy, Henan University, Kaifeng, China.
Shuocun WangSchool of Medicine, Shanghai University, Shanghai, China.
Tingfang WangSchool of Medicine, Shanghai University, Shanghai, China.
Liyan XiongSchool of Medicine, Shanghai University, Shanghai, China.
Jinghua HuangEight Plus One Pharmaceutical Co., Ltd, Guilin, China.
Xiaobin PangSchool of Pharmacy, Henan University, Kaifeng, China.
Yiming LuSchool of Medicine, Shanghai University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of ginger on gastrointestinal disorders such as ulcerative colitis have been widely investigated using experimental models; however, the mechanisms underlying its therapeutic actions are still unknown. In this study, we investigated the correlation between the therapeutic effects of ginger and the regulation of the gut microbiota. We used dextran sulfate sodium (DSS) to induce colitis and found that ginger alleviated colitis-associated pathological changes and decreased the mRNA expression levels of interleukin-6 and inducible nitric oxide synthase in mice. 16s rRNA sequencing analysis of the feces samples showed that mice with colitis had an intestinal flora imbalance with lower species diversity and richness. At the phylum level, a higher abundance of pathogenic bacteria,

Indexed as

16S rRNAcolitisdextran sodium sulfategingerintestinal microbiota

Identifiers

PMID33692694
PMCPMC7937968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.